Presentation TCT Abstracts Posters 2018 Radial Artery Flow Assessment After Diagnostic Coronary Angiography: Is Heparin That Important? Presenter: Dejan Jovic September 25, 2018
Presentation TCT 2017 Beyond Heparin: When and How to Escalate Therapy for Acute PE (Lytics, Catheter-Based, Surgery) Presenter: Peter P. Monteleone, Thomas M. Tu, Jay S. Giri November 01, 2017
Presentation TCT 2017 VALIDATE-SWEDEHEART NSTEMI: A Randomized Trial of Bivalirudin vs Heparin Monotherapy in Patients With NSTEMI Presenter: Thomas F. Luscher, David Erlinge October 31, 2017
Presentation TCT 2017 VALIDATE-SWEDEHEART STEMI: A Randomized Trial of Bivalirudin vs Heparin Monotherapy in Patients With STEMI Presenter: Y. S. Chandrashekhar, David J. Moliterno, Stefan K. James October 31, 2017
Presentation TCT 2017 Why I Prefer a Heparin Plus a GPI for Primary PCI in STEMI! Presenter: Michael S. Lee, Dirk Sibbing, Eric R. Bates October 30, 2017
Presentation TCT 2017 Why I Prefer Unfractionated Heparin Without GPI for Primary PCI in STEMI! Presenter: Michael S. Lee, Dirk Sibbing, A. Michael Lincoff October 30, 2017
Presentation ESC 2017 Bivalirudin vs Heparin Monotherapy in Myocardial Infarction:The VALIDATE-SWEDEHEART Trial Presenter: David Erlinge August 27, 2017
Presentation Primary PCI Outcomes in STEMI Patients Treated via Radial Access With Bivalirudin or Heparin May 23, 2017
Presentation TCT 2016 Do the Benefits of Bivalirudin Translate to Radial Intervention? Evidence From Randomized Trials Presenter: A. Michael Lincoff, Franz-Josef Neumann, John A. Bittl October 30, 2016
Presentation TCT 2016 Should Bivalirudin Only Be Used With a Prolonged Post-PCI Infusion? Presenter: A. Michael Lincoff, Franz-Josef Neumann, Gregg W. Stone October 30, 2016
Presentation TCT 2016 Start With a Three-way Debate: Bivalirudin Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI! Presenter: A. Michael Lincoff, Franz-Josef Neumann, Harvey D. White October 30, 2016
Presentation TCT 2016 Start With a Three-way Debate: Heparin Plus Routine Use of GP IIb/IIIa Inhibitors Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI! Presenter: A. Michael Lincoff, Franz-Josef Neumann, Jorge F. Saucedo October 30, 2016
Presentation TCT 2016 Start With a Three-way Debate: Heparin Monotherapy Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI! Presenter: A. Michael Lincoff, Franz-Josef Neumann October 30, 2016
Presentation TCT 2015 Bivalirudin Versus Unfractionated Heparin Analysis: What Is Really Best in Which Patients? Presenter: Carlo Briguori, Roxana Mehran, Carey D. Kimmelstiel October 15, 2015
Presentation TCT 2015 BRAVO 3: A Prospective Randomized Trial of Bivalirudin Versus Heparin in Patients Undergoing Transcatheter Aortic Valve Replacement Presenter: Thierry Lefevre October 15, 2015
Presentation TCT 2015 Debate: Bivalirudin vs Heparin During PCI in Stable CAD? Unfractionated Heparin! Presenter: John A. Bittl, Robert A. Harrington, Michael S. Lee October 12, 2015
Presentation TCT 2015 Debate: Bivalirudin vs Heparin During PCI in Stable CAD? Bivalirudin! Presenter: John A. Bittl, Robert A. Harrington, George D. Dangas October 12, 2015
Presentation TCT 2015 Bivalirudin vs Heparin in ACS: The New Data MATRIX Antithrombin Results Presenter: John A. Bittl, Robert A. Harrington, Marco Valgimigli October 12, 2015
Presentation TCT 2015 Pharmacology in the Lab: Heparin or Bivalirudin? Presenter: Robert J. Applegate, Ehtisham Mahmud October 11, 2015
Presentation BRIGHT: Bivalirudin vs Heparin With or Without Tirofiban During Primary PCI in Acute MI Presenter: Yaling Han March 23, 2015